(Q40444726)

20 September 2017

Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines (English)

1 reference

20 September 2017

Mohamed I Husseiny

1

1 reference

PubMed ID

15780440

20 September 2017

Michael Hensel

series ordinal

2

1 reference

PubMed ID

15780440

20 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

20 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

20 September 2017

23

1 reference

20 September 2017

20

1 reference

20 September 2017

2580-2590

1 reference

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Environmental regulation of Salmonella pathogenicity island 2 gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Identification of a pathogenicity island required for Salmonella survival in host cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Intracellular activities of Salmonella enterica in murine dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Synthesis of an ovalbumin-like protein by Escherichia coli K12 harbouring a recombinant plasmid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Type III secretion of Salmonella enterica serovar Typhimurium translocated effectors and SseFG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Construction of plasmid vectors with a non-antibiotic selection system based on the Escherichia coli thyA+ gene: application to cholera vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Construction, characterization, and immunogenicity of an attenuated Salmonella enterica serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing protective listerial epitopes within a surface-exposed loop of the TolC-protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Autodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Delivery of epitopes by the Salmonella type III secretion system for vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.11.035

1 reference

20 September 2017

1 reference

PubMed ID

15780440